JUL 07, 2016 07:44 AM PDT

MIT Researchers Create Customizable RNA Vaccines

Making and deploying vaccines can be costly and time-consuming. But, using a new technique that involves RNA and nanoparticles, researchers at the Massachusetts Institute of Technology (MIT) have developed a new type of vaccine that’s easily customizable. And best of all, vaccines with this technology take only seven days to make.

Programmable RNA vaccines now a possibility | Image: pixabay.com

Traditional vaccines are made with an inactivated or weakened (attenuated) form of a virus. The vaccine works by instigating a small immune response in the body. Through this process, the body develops antibodies that confer immunity to the virus or pathogen should it recognize it again in the future. Vaccines greatly reduce the risks of infection not only for the individual, but also for the community.

But the process of making vaccines is long and tedious work that sometimes don’t pan out because the disease pathogen is too wily. To circumvent this, MIT researchers turned to RNA – strands of genetic material that encode for proteins in living systems. In this case, the researchers used RNA that encoded specific proteins found in viruses, bacteria, or parasites. The idea is that once delivered into the host cells, the RNA message will be translated into proteins that will then instigate an immune response from the host – much in the same way that traditional vaccines work.

While the idea for RNA vaccines has been floating for 3 decades, it hasn’t been possible until now because of delivery obstacles. Researchers didn’t know yet how to package the RNA in a way that was effective and safe. To solve this problem, MIT researchers packaged RNA vaccines into nanoparticles that have the advantage of being positively charged. This allows a strong attraction to the RNA, which is negatively charged.

The new vaccines are purportedly fully customizable – all that’s needed is a protein-specific RNA sequence to a pathogen. Theoretically, this system can make vaccines using any viral, bacterial, or parasitic protein. Furthermore, the RNA vaccine can stimulate a stronger host immune response because it uses the host cells to make many copies of the encoded protein. By contrast, some traditional vaccines don’t produce enough of an immune response, which makes the vaccine ineffective unless researchers find a way to enhance the signal.

In lab trials, the RNA vaccines were administered via intramuscular injections. The vaccines also triggered both T cell response and antibody response, demonstrating the effectiveness of these RNA vaccine types. So far, the team has tested RNA vaccines on mice for Ebola, H1N1 influenza, and Toxoplasma gondii. "No matter what antigen we picked, we were able to drive the full antibody and T cell responses," said Omar Khan, a postdoc at the Koch Institute and co-first author of the study.

Another huge advantage to the RNA vaccines is the speed at which it can be manufactured. "Typically a vaccine becomes available long after the outbreak is over," said Jasdave Chahal, co-first author of the study. "We think we can become interventional over the course of a real outbreak." Indeed, the team reports that RNA vaccines can be made in about a week, as opposed to the months and even years using traditional methods.
"This nanoformulation approach allows us to make vaccines against new diseases in only seven days, allowing the potential to deal with sudden outbreaks or make rapid modifications and improvements," said Daniel Anderson, an associate professor at MIT, and senior study author.
The applications of RNA vaccines extend beyond infectious diseases. Already, the team is looking towards applying the same technology to create cancer vaccines that stimulate the host’s immune system to kill the tumor cells.

Additional source: MIT press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 28, 2018
Clinical & Molecular DX
MAY 28, 2018
Bacterial Toxin Linked to Inflammatory Bowel Disease
Scientists have found evidence that it's not a bacterium, but one of its toxins, that is connected to, and possibly causing intestinal dysfunction....
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Certain tests better flag fetuses with brain disorder risk
Fetuses with a specific, rare chromosomal aberration have a 20 percent risk of developmental or other brain disorder, new research shows. The work could le...
AUG 26, 2018
Genetics & Genomics
AUG 26, 2018
Why the Same Genetic Mutation can Affect People Differently
Scientists have been confounded for years by genetic errors with the sequence, but a different effect on people....
NOV 07, 2018
NOV 07, 2018
Inflammation Can Steal Your Sleep
A link between inflammation and the circadian rhythm has been determined in mouse models. High-fat-diets may be the cause....
DEC 05, 2018
DEC 05, 2018
Male Contraceptive Gel is in Clinical Trials
Researchers have started a clinical trial involving 420 participants to test the efficacy of a male contraceptive gel....
DEC 10, 2018
Health & Medicine
DEC 10, 2018
What To Expect During Your Stress Test
If you or a loved one has been scheduled for a treadmill stress test, you may be wondering what you can expect. The procedure is usually done in a hospital...
Loading Comments...